New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 22, 2013
05:55 EDTDNA, DNA, DNA, DNA, MNKD, MNKD, MNKD, MNKD, BMY, BMY, BMY, BMY, ARDM, ARDM, ARDM, ARDM, HGSI, HGSI, HGSI, HGSI, WST, WST, WST, WST, MEDI, MEDI, MEDI, MEDICambridge Healthtech Institute to host a conference
12th Annual Pep Talk: Protein Science Week is being held in Palm Springs, California on January 21-25.
News For DNA;MNKD;BMY;ARDM;HGSI;WST;MEDI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 30, 2014
07:41 EDTWSTWest Pharmaceutical reports Q3 adjusted EPS 44c, consensus 43c
Reports Q3 revenue $355.9M, consensus $356.08M.
07:15 EDTBMYASCO / ASTRO / IASLC to hold symposium
Subscribe for More Information
05:49 EDTBMYStocks with implied volatility movement; ARCP BMY
Subscribe for More Information
October 28, 2014
07:04 EDTBMYBristol-Myers enters agreement to acquire F-star Alpha, rights to FS102
Subscribe for More Information
07:03 EDTBMYBristol-Myers enters agreement to acquire F-star Alpha, rights to FS102
October 27, 2014
20:54 EDTBMYLeerink's major pharma analyst holds an analyst/industry conference call
Subscribe for More Information
October 24, 2014
16:02 EDTBMYOptions Update; October 24, 2014
Subscribe for More Information
11:15 EDTBMYBristol-Myers says has capacity for large deal
Subscribe for More Information
10:42 EDTBMYBristol-Myers sees coming in closer to high end of FY14 EPS guidance
Subscribe for More Information
10:10 EDTBMYBristol-Myers to host conference call
Conference call to review data presented at the Chicago Multidisciplinary Symposium on Thoracic Oncology (CMSTO) will be held on October 31 at 2:30 pm. Webcast Link
07:35 EDTBMYBristol-Myers reports Q3 Eliquis revenue $216M
Reports Q3 Baraclude revenue $325M, Sprycel revenue $385M, Yervoy revenue $350M. Reports Q3 Abilify revenue $449M, Orencia revenue $444M.
07:33 EDTBMYBristol-Myers confirms FY14 adjusted EPS view $1.70-$1.80, consensus $1.78
Cuts FY14 GAAP EPS view to $1.15-$1.25 from $1.50-$1.60. Both GAAP and non-GAAP guidance assume current exchange rates and that the R&D tax credit will be extended by Congress in 2014. Sees FY14 worldwide revenue $15.2B-$15.8B, consensus $15.58B. Also sees: Full-year gross margin as a percentage of revenues between 75% and 76%. Advertising and promotion expense decreasing in the mid-teen-digit range. Marketing, sales and administrative expenses decreasing in the mid-single-digit range. Research and development expenses growing in the mid-single-digit range. An effective tax rate of 19% - 20%.
07:31 EDTBMYBristol-Myers reports Q3 adjusted EPS 45c, consensus 42c
Subscribe for More Information
October 23, 2014
15:39 EDTBMYNotable companies reporting before tomorrow's open
Subscribe for More Information
October 22, 2014
05:58 EDTMNKDStocks with implied volatility movement; MNKD SHPG
Subscribe for More Information
October 21, 2014
08:03 EDTWSTWest Pharmaceutical receives approval for Vial2Bag DC device
Subscribe for More Information
07:15 EDTBMYFDA to hold workshop on breast cancer drug development
Subscribe for More Information
October 20, 2014
07:19 EDTBMYIBC Life Sciences to hold a conference
Subscribe for More Information
07:16 EDTDNAAmerican Academy of Ophthalmology to hold annual meeting
AAO Annual Meeting 2014 is being held in Chicago on October 18-21.
06:52 EDTMNKDMannKind initiated with a Neutral at Goldman
Target $6.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use